Skip to main content
LQDA
NASDAQ Life Sciences

Director Paul B Manning Files to Sell $11.1M in Liquidia Stock Amidst Broader Insider Distribution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$63
Mkt Cap
$5.562B
52W Low
$11.85
52W High
$66.24
52W Position info
432% above low
Off High info
4.9% below high
Rel. Volume info
3.1× avg
Market data snapshot near publication time

LQDA has more than doubled off its 52-week low of $11.85 on elevated volume (3.1× avg).

Summary

Director Paul B Manning has filed a Form 144 to sell $11.1 million in Liquidia Corp common stock, contributing to a notable trend of insider distribution as the stock trades near its 52-week high.


Key Events · Ownership and Investor Activity · LQDA

  • Director Plans Significant Sale

    Paul B Manning, a Director, intends to sell 200,000 shares of common stock valued at approximately $11.1 million.

  • Continuation of Insider Selling Trend

    This filing follows a pattern of substantial insider sales, with over $66 million in net sales by 11 active insiders in the past 90 days, including multiple Form 144 filings by directors and affiliated entities.

  • Stock Trading Near 52-Week High

    The planned sale occurs while Liquidia's stock is trading close to its 52-week high, suggesting insiders may be locking in gains.


Analysis · LQDA · Life Sciences

Director Paul B Manning's intent to sell $11.1 million worth of common stock adds to a significant pattern of insider selling at Liquidia Corp, which has seen over $66 million in net sales by insiders in the last 90 days. This selling occurs while the stock is trading near its 52-week high, potentially indicating profit-taking by insiders despite recent positive earnings reports. The ongoing patent and trade secret litigation mentioned in the Q1 2026 report could be a factor influencing these sales.

At the time of this filing, LQDA was trading at $63.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.6B. The 52-week trading range was $11.85 to $66.24. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LQDA - Latest Insights

LQDA
Jun 12, 2026, 4:30 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $71.23
Real-time Price: $80.06 info
Change: +$8.83 (+12%) info
Market Cap: $7.109B info
LQDA
Jun 10, 2026, 4:52 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $65.31
Real-time Price: $80.06 info
Change: +$14.75 (+23%) info
Market Cap: $7.109B info
LQDA
Jun 08, 2026, 4:41 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $64.69
Real-time Price: $80.06 info
Change: +$15.37 (+24%) info
Market Cap: $7.109B info
LQDA
Jun 08, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $64.69
Real-time Price: $80.06 info
Change: +$15.37 (+24%) info
Market Cap: $7.109B info
LQDA
Jun 08, 2026, 4:11 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $63.90
Real-time Price: $80.06 info
Change: +$16.16 (+25%) info
Market Cap: $7.109B info
LQDA
Jun 04, 2026, 6:38 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $63.00
Real-time Price: $80.06 info
Change: +$17.06 (+27%) info
Market Cap: $7.109B info
LQDA
Jun 04, 2026, 5:24 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $62.50
Real-time Price: $80.06 info
Change: +$17.56 (+28%) info
Market Cap: $7.109B info
LQDA
May 26, 2026, 6:17 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $60.63
Real-time Price: $80.06 info
Change: +$19.43 (+32%) info
Market Cap: $7.109B info
LQDA
May 21, 2026, 5:12 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $61.70
Real-time Price: $80.06 info
Change: +$18.36 (+30%) info
Market Cap: $7.109B info
LQDA
May 20, 2026, 4:37 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $61.77
Real-time Price: $80.06 info
Change: +$18.29 (+30%) info
Market Cap: $7.109B info